STOK R&D to Revenue
Stoke Therapeutics Inc · R&D to Revenue
STOK R&D to Revenue
Latest reported525.93%period ending
STOK Quarterly R&D/Revenue (0.00% → 525.93%)
Latest values, visible window
High-resolution chart · PNG
STOK r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 525.9303% | |
| 636.908% | |
| 2,945.0785% | |
| 350.395% | |
| 187.1246% | |
| 20.6068% | |
| 103.5774% | |
| 453.7188% | |
| 426.1644% | |
| 517.1964% | |
| 754.9607% | |
| 593.5308% | |
| -803.7082% | |
| 369.4488% | |
| 625.6348% | |
| 678.864% | |
| 558.8363% | |
| 602.0667% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |